Investing.com - Beauty Health Co (NASDAQ: SKIN) reported third quarter EPS of $-0.56, $0.63 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $97.4M versus the consensus estimate of $116.23M.
Guidance
Beauty Health Co sees FY 2023 revenue of $385.00M-$400.00M versus the analyst consensus of $461.30M.
Beauty Health Co's stock price closed at $3.90. It is down -32.53% in the last 3 months and down -61.76% in the last 12 months.
Beauty Health Co saw 0 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Beauty Health Co's stock price’s past reactions to earnings here.
According to InvestingPro, Beauty Health Co's Financial Health score is "fair performance".
Check out Beauty Health Co's recent earnings performance, and Beauty Health Co's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar